Clinical Trial Update: The HDL Particle Protection Study [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial update for the HDL Particle Protection Study has completed, investigating dyslipidemia in patients with diabetes mellitus.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetes Mellitus
• Dyslipidemia

Snippet

Sponsor: Hotel Dieu de France Hospital | Conditions: Dyslipidemia in Patients With Diabetes Mellitus | Phase 4 | Status: COMPLETED